fenofibrate has been researched along with Arrhythmogenic Right Ventricular Dysplasia in 1 studies
Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE
Arrhythmogenic Right Ventricular Dysplasia: A congenital cardiomyopathy that is characterized by infiltration of adipose and fibrous tissue into the RIGHT VENTRICLE wall and loss of myocardial cells. Primary injuries usually are at the free wall of right ventricular and right atria resulting in ventricular and supraventricular arrhythmias.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Qiu, Z | 1 |
| Zhao, Y | 1 |
| Tao, T | 1 |
| Guo, W | 1 |
| Liu, R | 1 |
| Huang, J | 1 |
| Xu, G | 1 |
1 other study available for fenofibrate and Arrhythmogenic Right Ventricular Dysplasia
| Article | Year |
|---|---|
Activation of PPARĪ± Ameliorates Cardiac Fibrosis in Dsg2-Deficient Arrhythmogenic Cardiomyopathy.
Topics: Animals; Arrhythmogenic Right Ventricular Dysplasia; Biomarkers; Collagen Type I; Desmoglein 2; Dise | 2022 |